We have previously reported the construction and efficacy of NZ-1-CAR-T cells that target PDPN;12 however, NZ-1 CAR-T cells may have an on-target-off-tumor effect because they may recognize low levels of PDPN even in normal tissues. The gene discussed is PDPN; the disease is neoplasm.